About Us

Research

Drug Trends

Information and Education

Media

Publications

Links

For Staff

Faculty of Medicine

National Drug and Alcohol Research Centre

Other NDARC Research Websites

Current Research

The following projects are listed under the headings identified in the 2004-2008 Strategic Plan as research priorities for NDARC:

Epidemiology
Identification of potential harms
Health economics
Drug market analysis and supply reduction
Prevention and early interventions
Treatment and other interventions
Information and training
Drug Policy Modelling Program

Epidemiology

National illicit drug indicators project (NIDIP) (E4)

Mortality among opioid dependent persons in pharmacotherapy, NSW 1985-2006 (E5)

The health and psychological consequences of ecstasy use (E6)

Secretariat of the reference group to the United Nations on HIV and injecting drug use (E7)

Using epidemiology to inform psychiatric classification (DSM-V and ICD-11) (E8)

Global burden of disease: Mental disorders and illicit drug use expert group (E10)

Study on HIV incidence among IDUs in Northern Shan States, Burma (E11)

Alcohol related crime in the Sydney Local Government Area (E12)

Alcohol use in pregnancy (E13)

Identification of potential harms

Cannabis cohort research consortium (I26)

Ten-year follow up of a cohort of heroin dependent prisoners (I28)

Attitudes towards, knowledge of, and prevalence of illicit drug use among elite athletes (I29)

The characteristics of cannabis in Australia (I30)

Impact of parental substance use on infant development and family functioning: A pilot study (I31)

Issues related to substance use among university student athletes (I32)

Health economics

Building capacity in health economics (H7)

Drug market analysis and supply reduction

The illicit drug reporting system (IDRS) (D1)

The ecstasy and related drugs reporting system (EDRS) (D2)

Prevention and early interventions

Alcohol action in rural communities (AARC) (P6)

CLIMATE schools: The development and evaluation of an interactive computer-based prevention program for cannabis and psychostimulants (P9)

Climate schools: Ecstasy Module (P13)

Treatment and other interventions

Methamphetamine treatment evaluation study: MATES (T19)

The introduction of Suboxone� (buprenorphine-naloxone) in Australia: Monitoring the extent of diversion and related harms (T27)

The efficacy of an intervention for post traumatic stress disorder (PTSD) among illicit drug users (T32)

Integrating treatment for alcohol use problems and comorbid post traumatic stress disorder (PTSD) (T33)

Development and evaluation of specialist services for female drug users in Iran (T35)

Clinical guidelines for the management of cannabis use disorder (T38)

Child protection and mothers in substance abuse treatment (T39)

Suicide risk assessment and intervention strategies: Current practices among drug and alcohol treatment providers (T40)

Evaluation of the connections project (T41)

Fine-related debt among substance-using offenders (T42)

Magistrates early referral into treatment (MERIT) research bulletins (T43)

Improving shared healthcare for methadone patients with Hepatitis C (T44)

The development and evaluation of a treatment and relapse prevention program for juvenile offenders aimed at reducing substance use and criminal behavior (T45)

The Michael Project Evaluation (T46)

Qualitative study of mental health and mental health treatment among young cannabis and psychostimulant users in residential substance abuse treatment (T47)

Self-managed change from problematic cannabis use: A web-based survey (T48)

Screening and brief intervention in Aboriginal controlled community health services in rural NSW (T49)

Information and training

Program of international research and training (PIRT) (IT4)

National Comorbidity Clinical Guidelines (IT18)

Printer Friendly Page

Copyright & Disclaimer

National Drug and Alcohol Research Centre - UNSW - Faculty of Medicine NSW 2052 Australia | Tel: +61 (2) 9385 0333 Fax: +61 (2) 9385 0222
© Copyright 2005 UNSW Faculty of Medicine | CRICOS Provider Code: 00098G | Authorised by Centre Director
Page Last Updated: 11:04:56 AM, Wednesday 18 November 2009